-
Company Insights
NewInnovation and Patenting activity of AGC Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of AGC Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
AGC Vinythai Map Ta Phut Complex, Thailand
Each petrochemical complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total annual capacity of the complex. We also provide contractor details such as EPC/Design & FEED contractors for the petrochemical complex. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day...
-
Company Profile
AGC Inc – Company Profile
AGC Inc (AGC), formerly Asahi Glass Co Ltd, is a provider of glass, electronic components, chemicals and ceramics. The company's product portfolio comprises float flat glass, automotive glass, decorative glass, heat insulating and shielding glass, architectural glass, disaster-resistant and security glass and polished wired glass. It also offers LCD glass substrates, specialty glass for display applications, cover glass for car-mounted displays, glass for solar power system, fabricated glass for industrial use and optoelectronic and lightening glass products. AGC provides polyvinyl...
Add to Basket -
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HHSCC-244 in Non-Small Cell Lung Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HHSCC-244 in Non-Small Cell Lung Cancer Drug Details: Glumetinib (HHSCC-224) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gumarontinib in Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Gumarontinib in Non-Small Cell Lung CancerDrug Details:Glumetinib (Haiyitan) is an anti neoplastic agent which inhibit the...
-
Product Insights
NewAsahi Kitakyushu – Asahi Solar PV Park
Asahi Kitakyushu - Asahi Solar PV Park is a solar PV project located in Fukuoka, Japan. The project is owned and developed by AGC Inc; Saibu Gas Co Ltd. The project came online in 2014. Empower your strategies with our Asahi Kitakyushu - Asahi Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tepotinib Hydrochloride in Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Tepotinib Hydrochloride in Colorectal Cancer Drug Details: Tepotinib hydrochloride (Tepmetko) is anti neoplastic agent. It is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tepotinib Hydrochloride in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Tepotinib Hydrochloride in Solid Tumor Drug Details: Tepotinib hydrochloride (Tepmetko) is anti neoplastic agent. It is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tepotinib Hydrochloride in Gastroesophageal (GE) Junction Carcinomas
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Tepotinib Hydrochloride in Gastroesophageal (GE) Junction Carcinomas Drug Details: Tepotinib hydrochloride (Tepmetko) is anti neoplastic agent....
-
Track & Monitor
NewInnovation in automotive: Self-sensing laminated glass
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the automotive industry’s Self-sensing laminated glass innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience...